Effects of high-fat diet on 1,2-dimethylhydrazine-induced aberrant crypt foci and colorectal tumours in rats

Abstract

Obesity is one of the leading causes of numerous types of cancer. The present study investigated the impact of a high-fat diet on 1,2-dimethylhydrazine (DMH)-induced colorectal cancer (CRC) in F344 rats. A total of 16 male F344 rats aged 4 weeks were randomly divided into two groups (8 rats/group). Rats in group A were fed a basal diet with a moderate fat (MF) content, while rats in group B were fed a high-fat diet. Upon reaching 5 weeks of age, the rats were injected subcutaneously with DMH (20 mg/kg body weight). DMH was administered once a week for 8 consecutive weeks. All the rats were sacrificed 34 weeks after the first DMH injection and dissected to obtain samples of colorectal tissues. The tissues were examined under a microscope for the presence of aberrant crypt foci (ACFs) and subjected to histopathological analysis. The results showed that at the end of the 34-week experiment, body weights and visceral fat levels were significantly higher in the high-fat diet group compared to the basal diet group. In addition, the incidences of colorectal ACF, adenoma and adenocarcinoma were markedly elevated in the high-fat diet group compared to the basal diet group. These results indicate that the consumption of a high-fat diet promotes the development and progression of CRC and the control of fat intake may prevent CRC.

Introduction

Colorectal cancer (CRC) is the second and third most common malignancy in females and males, respectively, worldwide. Colon cancer is considered to be one of the leading causes of mortality in the world. There are extremely few therapeutic agents capable of effectively treating colon cancer (1). According to the GLOBOCAN database established by the World Health Organization (WHO), an estimated 12.7 million new cancer cases and 7.6 million cancer fatalities occurred in 2008 (2). The incidence of CRC is rising rapidly in numerous Asian countries and approaching the incidence in developed countries (3). Studies have shown that the incidence of malignant tumours has declined in males and females in the United States and one of the notable contributing factors is the decreased incidence of CRC. The results indicate that CRC occupies a predominant position among the malignancies in the United States (4). African-Americans have experienced an increased incidence of CRC compared to other U.S. populations. In addition, the prevalence of proximal CRC is higher among African-Americans and the average age for the onset of CRC is becoming younger (5). CRC is one of the common malignancies in China. The mortality rate of CRC in China is 4.54 per 100,000 population, which accounts for 4.9% of all cancer fatalities and ranks as the fifth highest among the malignant tumours. Notably, thus far the incidence and mortality rate of CRC continues to exhibit a tendency to increase. The five-year survival rates of CRC after curative resection remain near 50% (for rectal cancer) and 70% (for colon cancer). CRC is closely associated with the lifestyle of Western countries. Lifestyle and dietary patterns affect the risk of colon cancer. Among dietary factors, high intakes of red meat, fat and carbohydrates enhance the risk of developing CRC. By contrast, increased consumption of fruits, vegetables and fibres may reduce the incidence of CRC (6–8). The report released by the WHO and the Food and Agriculture Organization of the United Nations (FAO) in 2003 clearly stated that obesity is a risk factor for CRC (9). 1,2-Dimethylhydrazine (DMH) is a carcinogenic agent widely utilised to induce CRC in rats and other animal models. DMH is also commonly employed in chemistry-based cancer prevention studies (10). The present study mainly investigated the effects of a high-fat diet on DMH-induced CRC in F344 rats.

Materials and methods

Animals

A total of 16 male 4-week-old F344 rats were purchased from Charles River Laboratories Japan, Inc. (Kanagawa, Japan). The animals were cared for in compliance with the principles and guidelines of Ethical Committee for Animal Care and Institutional Animal Ethical Committee, in accordance with the Japan National Law on Animal Care and Use. The Ethical Committee for Animal Care of the Prefectural University of Hiroshima (Hiroshima, Japan) approved the experiments undertaken. The rats were housed in a standard air-conditioned room at the Laboratory Animal Research Center of the Prefectural University of Hiroshima. The room provided a controlled ambient temperature of 23±2°C, a humidity of 50±10% and a daily light period of 12 h. The rats had free access to drinking water and were fed either a basal diet [moderate fat (MF)] or a high-fat diet (Oriental Yeast Co., Ltd., Tokyo, Japan). The main composition of the high-fat diet included lard, a fish meal, defatted soybean, vitamins and minerals (Table I). The contents of the three major types of nutrients in the high-fat and basal diets were compared and summarised in Table II. The contents of proteins, fats and carbohydrates were 60, 24.5 and 7.5 g, respectively, in 100 g of the high-fat diet and 23.6, 5.3 and 54.4 g, respectively, in the basal diet. The body weights of the rats were recorded once every two weeks. DMH was purchased from Tokyo Chemical Industry Co., Ltd., (Tokyo, Japan).

Table I.

Contents of the high-fat diet.

Nutrient composition of the high-fat diet	%
Lard	58
Fish meal	30
Defatted soybean	10
Vitamins, minerals and other components	2

Table II.

Contents of the three major types of nutrients in the basal and high-fat diets (100 g).

Nutrients	Basal diet	High-fat diet
Protein, g	23.6	24.5
Fat, g	5.3	60
Carbohydrate, g	54.4	7.5
Total energy, kcal	360	640

Experimental protocol

The experimental design is shown in Fig. 1. The 16 male rats were randomly divided into two groups (8 rats/group) based on their diets: Group A, basal diet; group B, high-fat diet. DMH was dissolved in 0.9% sodium chloride and the pH value was adjusted to 6.5 with NaHCO₃. Upon reaching 5 weeks of age, the experimental rats were injected subcutaneously with DMH (20 mg/kg body weight) once a week for 8 consecutive weeks. All the rats were sacrificed 34 weeks after the first DMH injection and dissected to obtain samples of colorectal tissues. The tissues were examined under a microscope for the presence of aberrant crypt foci (ACFs) and subjected to histopathological analysis.

Figure 1.

Experiment protocol. MF, moderate fat; DMH, 1,2-dimethylhydrazine.

Analysis of ACFs and histological analysis

In rodents and humans, ACFs are believed to be the microscopic damage formed at the earliest stage of CRC development. ACFs may be the precancerous lesions that emerge prior to dysplasia (11). DMH-induced intestinal mucosal injury is a multi-step pathological process that involves the formation of ACFs, a gradual increase in the number of ACFs and eventually the development of CRC (12). The emergence of ACFs is closely associated with DMH. DMH is converted into azoxymethanol in vivo, which is further decomposed to form alkylated methyl diazonium. The product induces the methylation of DNA, RNA and proteins. DNA methylation results in chromosomal gene mutations and tumour cell formation. A study conducted by Tanaka (13) has shown that the DNA sequence of proto-oncogene K is mutated in ACFs, leading to the formation of adenomas. Subsequently, DNA repair errors and p53 gene mutation occur and adenomas develop further into adenocarcinomas.

After the animals were sacrificed, the entire colorectum was quickly removed and cut open along the longitudinal axis. The colorectal samples were rinsed clean with precooled 0.9% NaCl solution and laid onto filter paper with the mucosal side up. After 24 h of fixation at 4°C in 10% buffered formalin, the colorectal samples were stained with 0.5% methylene blue for 15–30 min, washed with distilled water, placed on glass slides and observed under an optical microscope using the 4 and 10X objectives. The number of ACFs was recorded. After the ACFs were recorded and calculated, the colorectal samples were fixed with 10% buffered formalin, embedded in paraffin, sectioned at a thickness of 4 µm, stained with hematoxylin and eosin and examined under an optical microscope (Olympus, Tokyo, Japan). The number of tumours was counted and tumour types and grades were investigated.

Statistical analysis

The Statcel software package (KaleidaGraph version 4.1) was used for analysis. The Fisher's exact test and t-test (Statcel, the useful add in forms on Excel; 2nd edition) were used to compare data between the two groups. P<0.05 was considered to indicate a statistically significant difference.

Results

Body weight and visceral fat content

Fig. 2A shows no significant differences in body weight between the two groups of rats within the first 14 weeks of the experiment. However, compared to the rats in the basal diet group, the rats in the high-fat diet group experienced significantly greater weight gains after 14 weeks. At the end of the 34-week experiment, body weights of the rats in the high-fat diet group were significantly higher compared to the rats in the basal diet group (418.6±14.9 vs. 381.9±20.9 g; P<0.05). For the purpose of the study, the amount of visceral fat was calculated as the sum of the amount of body fat deposited in the greater omentum and testicles. The amounts of visceral fat in the two groups of rats were determined and are shown in Fig. 2B. The amount of visceral fat was significantly increased in the high-fat diet group compared to that of the basal diet group (19.2±1.9 vs. 13.1±1.9 g; P<0.01). The average daily energy intake in each rat from the high-fat diet group was ~1.3-fold higher compared to that of the basal diet group and the average daily fat intake in each rat from the high-fat diet group increased ~8-fold compared to that of the basal diet group (data not shown).

Figure 2.

Body weights and visceral fat content of the different groups of F344 rats throughout the experiment. (A) The body weights of the different groups of F344 rats. (B) Visceral image of the different groups of rats; (a) moderate fat (MF) and (b) high-fat diet groups. (C) Visceral fat content of the different groups of F344 rats, **P<0.01.

Colonic ACFs

The effect of the tested diets on the growth and development of DMH-induced ACFs in rats is shown in Fig. 3. All the rats treated with DMH showed a 100% incidence. The high-fat diet group showed a significantly higher average number of ACFs than that of the MF diet group.

Figure 3.

Aberrant crypt foci (ACFs) expression in the colon of rats treated with 1,2-dimethylhydrazine (DMH) and stained with 0.5% methylene blue at week 34. (A) ACF expression in the colon of rats treated with DMH and stained with 0.5% methylene blue. (a) ACF expression in the colon from a rat in the modified fat (MF) group. Arrows point to the four and five crypts in the colon. (b) ACF expression in the colon of a rat in the high-fat diet group. Arrows point to the multiple crypts in the colon. (B) Number of ACFs in the colon, **P<0.01.

Colon tumours

The colorectal tissue sections were subjected to histopathological investigation and the results are summarised in Tables III and IV, and Fig. 4. Tables III and IV show that at the 34th week of the experiment, the incidence of colorectal adenomas and adenocarcinomas was significantly higher in the high-fat diet group compared to that of the basal diet group. A total of 119 adenomas were detected in the basal diet group, including 103 low-grade and 16 moderate-grade adenomas. The average number of adenomas developed in each rat was 14.8±8.5. By contrast, 175 adenomas were detected in the high-fat diet group, including 141 low-grade, 30 moderate-grade and 4 high-grade adenomas. The average number of adenomas observed in each rat was 21.9±7.2. The differences in the adenoma incidence between the two groups of rats were statistically significant (P<0.01). In addition, the numbers of highly, moderately and poorly differentiated adenocarcinomas found in the basal diet group were 4, 1 and 3, respectively. An average of 1.0±0.8 adenocarcinomas were developed in each rat. By contrast, the numbers of highly, moderately and poorly differentiated adenocarcinomas detected in the high-fat diet group were 16, 3 and 1, respectively. An average of 2.5±1.1 adenocarcinomas were developed in each rat. The differences in the adenocarcinoma incidence between the two groups of rats were also statistically significant (P<0.01).

Table III.

Number of colon adenomas.

	No. of colon adenomas
Group	Mild-grade dysplasia	Moderate-grade dysplasia	Severe-grade dysplasia	Total	No. of colon adenomas per rat
A	103	16	0	118	14.8±8.54a
B	141	30	4	175	21.9±7.19

^aP<0.01.

Table IV.

Number of colon adenocarcinomas per rat.

	No. of colon adenocarcinomas
Group	Well-differentiated adenocarcinomas	Moderately differentiated adenocarcinomas	Poorly differentiated adenocarcinomas	Total	No. of colon adenocarcinomas per rat
A	4	1	3	8	1.0±0.83a
B	16	3	1	20	2.5±1.07

^aP<0.01.

Figure 4.

1,2-Dimethylhydrazine-induced colorectal tumours in rats. (A) Hyperplasia. (B) Adenoma with mild atypia. (C) Adenoma with moderate atypia. (D) Well-differentiated tubular adenocarcinomas. (E) Moderately differentiated adenocarcinomas. (F) Poorly differentiated adenocarcinomas. Haematoxylin and eosin stains (magnification, x200).

Discussion

Obesity is one of the leading causes of numerous types of cancer. The report released by the WHO and the FAO in 2003 clearly stated that obesity is a risk factor for CRC (9). Investigators in the U.S. have conducted studies on the potential link between obesity and cancer and found that in males and females, kidney cancer and cancers of the digestive system, such as oesophageal cancer, CRC, hepatobiliary and pancreatic cancers, are associated with obesity, as defined by high body mass index values (14). Relevant studies have shown that obese populations with high blood sugar levels have almost double the risk of developing obesity-related cancers, while obese populations with normal blood sugar levels only carry a 50% increased risk of developing cancers. In addition, metabolic dysfunction also increases the risk of cancer in obese individuals (15). In the present study, CRC was induced in rats using DMH. The rats were fed a high-fat diet and the effect of the high-fat diet-induced obesity on rat CRC was investigated. The results showed that after 14 weeks, the rats in the high-fat diet group experienced a significantly greater body weight gain compared to the rats in the basal diet group. At the end of the 34-week experiment, the average difference in body weights between the two groups of rats was ~40 g. The level of visceral fat was significantly higher in rats from the high-fat diet group compared to the rats from the basal diet group. In addition, the incidence of ACF, adenomas and adenocarcinomas was markedly elevated in the high-fat diet group compared to the basal diet group. The above results indicate that a high-fat diet promotes the development and progression of CRC in rats.

The mechanisms by which obesity induces CRC may be associated with insulin-resistant hyperinsulinaemia and insulin-like growth factors (IGFs) (14,16). To maintain normal blood sugar levels and carbohydrate metabolism, patients with insulin resistance require a large amount of insulin. A variety of conditions, such as obesity, inflammation and hyperlipidaemia, may result in the loss of normal insulin function. Obesity causes insulin resistance and hyperinsulinaemia. Shortly following the inhibition of insulin, the secretion and expression of IGF binding protein are altered, which increases the amount of free IGFs. Insulin and IGF-1 are growth factors that promote cell proliferation and inhibit apoptosis in cancer cells, resulting in tumour development and progression. Blood insulin levels measured in CRC patients and healthy individuals before breakfast and at 90 minutes after breakfast or lunch have shown that an increased IGF-1 level is associated with the incidence of CRC (17). In addition, the levels of C-peptide have been analysed in CRC patients and healthy individuals. The group with the highest C-peptide value exhibits a 3.2-fold increase in CRC risk compared to the group with the lowest C-peptide value. Higher C-peptide values indicate a greater risk of CRC (17,18).

In addition to insulin resistance, high-fat diet-induced bile acid secretion also promotes CRC development. Increased animal fat intake enhances the levels of secreted bile acids and cholesterol in bile. Bile acids and cholesterol are converted to secondary bile acids and steroids by bacteria in the colon, which are further metabolised by colonic bacteria into carcinogens (19). Animal experiments have shown that a high-fat diet increases bile acid secretion. Bile acids exhibit no direct carcinogenic effects; however, they increase the rate of cancer induction by carcinogens through accelerating cell turnover (20). This study showed that the consumption of a high-fat diet significantly increased the incidence of colorectal adenomas and adenocarcinomas, indicating that the cancer-promoting effect of a high-fat diet is associated with the increased secretion of bile acids. In addition, bile acids induce the expression of cyclooxygenase-2 (Cox-2) in CRC cells (21). Cox-2 is rarely expressed in the majority of normal tissues but is highly expressed in cancer cells. Cox-2 inhibits apoptosis in cancer cells and promotes angiogenesis (21–23). In addition, secondary bile (docosahexaenoic acid) triggers the production of the receptor of urokinase-type activating factor and is associated with the increased invasiveness of CRC cells (24).

Obesity is a strong risk factor for CRC. Adiponectin (APN) is a lipid factor secreted by adipose tissue that exhibits an immune-modulatory, anticancer effect in carbohydrate and lipid metabolism in CRC. A number of studies have shown that obesity is associated with APN and the incidence of CRC (25–29). Wei et al (30) found that the level of APN was reduced in obese individuals. APN deficiency induces chronic inflammation of the large intestine, which may further develop into CRC and increase the risk of developing cancer. Saxena et al (31) have investigated DMH-induced CRC under the condition of APN deficiency and identified that experimental animals deficient in APN clearly exhibit the clinical symptoms of carcinogenesis.

The consumption of a high-fat diet induces insulin resistance and increases bile secretion. The products of lipid metabolism exhibit mutagenic effects on DNA and RNA. In addition, the APN level is reduced in individuals with a high body fat level. Therefore, a high-fat diet promotes the development of CRC. Exercise may have a preventive effect against CRC. It is also necessary to maintain a nutritionally balanced diet and avoid excess fat intake. The present study also showed that the consumption of a high-fat diet promoted the development and progression of CRC. Therefore, controlling fat intake may prevent CRC.